✦ LIBER ✦

Ovarian serous borderline tumors with invasive peritoneal implants

✍ Scribed by David M. Gershenson; Elvio G. Silva; Lawrence Levy; Thomas W. Burke; Judith K. Wolf; Carmen Tornos

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 324 KB
Volume: 82
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19980315)82:6<1096::aid-cncr13>3.0.co;2-1

No coin nor oath required. For personal study only.

✦ Synopsis

multivariate regression analyses also were performed. University of Texas M. D. Anderson Cancer Cen-RESULTS. Median follow-up time was 111 months. Four of 7 evaluable patients ter, Houston, Texas.

who had second-look surgery (57%) had a response to chemotherapy. Twelve of

📜 SIMILAR VOLUMES

Serous borderline tumors of the ovary wi

Serous borderline tumors of the ovary with noninvasive peritoneal implants

✍ David M. Gershenson; Elvio G. Silva; Guillermo Tortolero-Luna; Charles Levenback 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## BACKGROUND. The authors conducted this study to update their experience with patients who have ovarian serous borderline tumors with noninvasive peritoneal implants, with the objectives of gaining additional insight into the biologic behavior of these tumors and understanding better the effects

The current status of surgical staging o

The current status of surgical staging of ovarian serous borderline tumors

✍ Paul S. Lin; David M. Gershenson; Michael W. Bevers; Kristin R. Lucas; Thomas W. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Background: The purpose of the current study was to evaluate the current practice of surgical staging of ovarian serous borderline tumors. ## Methods: Women with a diagnosis of ovarian serous borderline tumors whose pathology slides were sent to the m. d. anderson cancer center for second-opin

Peritoneal papillary serous carcinoma: S

Peritoneal papillary serous carcinoma: Study of 15 cases and comparison with stage iii–iv ovarian papillary serous carcinoma

✍ Piura, Benjamin; Meirovitz, Mihai; Bartfeld, Mary; Yanai-Inbar, Ilana; Cohen, Yo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

Background and Objectives: Peritoneal papillary serous carcinoma (PPSC) is histologically and clinically similar to stage III-IV ovarian papillary serous carcinoma (OPSC). The purpose of this study was to investigate the clinical findings, treatment, and outcome of PPSC patients compared with stage

Identification of allelic losses in beni

Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome

✍ Gabriele Saretzki; Uwe Hoffmann; Peter Röhlke; Roland Psille; Thorwald Gaigal; G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

18q, and 22q were analyzed by polymerase chain reaction for loss of heterozygosity Gisela Keller, Ph

Expression of vascular endothelial growt

Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors

✍ G. Gioele Garzetti; Andrea Ciavattini; Guendalina Lucarini; Armanda Pugnaloni; M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The aim of the current study was to investigate the expression of vascular endothelial growth factor (VEGF) by neoplastic cells in patients with serous ovarian tumors. The correlation between neoangiogenesis and 72-kilodalton metalloproteinase (MMP2) immunostaining also was evaluated. ## METHODS.

Numerical abnormalities of chromosomes 1

Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours

✍ Evans, Mark F.; McDicken, Ian W.; Herrington, C. Simon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

The clinical behaviour of ovarian tumours of low malignant potential (LMP) is unpredictable and it has been suggested that the majority of these lesions have no invasive potential. This study has analysed 92 epithelial ovarian tumours [11 mucinous cystadenomas, 18 mucinous LMP tumours, 15 mucinous c